Literature DB >> 15528712

characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling.

G B Rogers1, M P Carroll, D J Serisier, P M Hockey, G Jones, K D Bruce.   

Abstract

Progressive loss of lung function resulting from the inflammatory response to bacterial colonization is the leading cause of mortality in cystic fibrosis (CF) patients. A greater understanding of these bacterial infections is needed to improve lung disease management. As culture-based diagnoses are associated with fundamental drawbacks, we used terminal restriction fragment (T-RF) length polymorphism profiling and 16S rRNA clone data to characterize, without prior cultivation, the bacterial community in 71 sputa from 34 adult CF patients. Nineteen species from 15 genera were identified in 53 16S rRNA clones from three patients. Of these, 15 species have not previously been reported in CF lung infections and many were species requiring strict anaerobic conditions for growth. The species richness and evenness were determined from the T-RF length and volume for the 71 profiles. Species richness was on average 13.3 +/- 7.9 per sample and 13.4 +/- 6.7 per patient. On average, the T-RF bands of the lowest and highest volumes represented 0.6 and 59.2% of the total volume in each profile, respectively. The second through fifth most dominant T-RF bands represented 15.3, 7.5, 4.7, and 2.8% of the total profile volume, respectively. On average, the remaining T-RF bands represented 10.2% of the total profile volume. The T-RF band corresponding to Pseudomonas aeruginosa had the highest volume in 61.1% of the samples. However, 18 other T-RF band lengths were dominant in at least one sample. In conclusion, this reveals the enormous complexity of bacteria within the CF lung. Although their significance is yet to be determined, these findings alter our perception of CF lung infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528712      PMCID: PMC525137          DOI: 10.1128/JCM.42.11.5176-5183.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.

Authors:  Dieter Worlitzsch; Robert Tarran; Martina Ulrich; Ute Schwab; Aynur Cekici; Keith C Meyer; Peter Birrer; Gabriel Bellon; Jürgen Berger; Tilo Weiss; Konrad Botzenhart; James R Yankaskas; Scott Randell; Richard C Boucher; Gerd Döring
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  High diversity in DNA of soil bacteria.

Authors:  V Torsvik; J Goksøyr; F L Daae
Journal:  Appl Environ Microbiol       Date:  1990-03       Impact factor: 4.792

Review 3.  Transition of care between paediatric and adult gastroenterology. Cystic fibrosis.

Authors:  Reuben Jackson; Paul B Pencharz
Journal:  Best Pract Res Clin Gastroenterol       Date:  2003-04       Impact factor: 3.043

4.  Bacteriology of chronic maxillary sinusitis in adults.

Authors:  I Brook
Journal:  Ann Otol Rhinol Laryngol       Date:  1989-06       Impact factor: 1.547

5.  Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov.

Authors:  Tom Coenye; Johan Goris; Theodore Spilker; Peter Vandamme; John J LiPuma
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

6.  Bilophila wadsworthia, gen. nov. and sp. nov., a unique gram-negative anaerobic rod recovered from appendicitis specimens and human faeces.

Authors:  E J Baron; P Summanen; J Downes; M C Roberts; H Wexler; S M Finegold
Journal:  J Gen Microbiol       Date:  1989-12

7.  Bilophila wadsworthia bacteremia in two patients with hepatic abscesses.

Authors:  M J Kasten; J E Rosenblatt; D R Gustafson
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

8.  Human fecal flora: the normal flora of 20 Japanese-Hawaiians.

Authors:  W E Moore; L V Holdeman
Journal:  Appl Microbiol       Date:  1974-05

9.  Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

Authors:  J J Smith; S M Travis; E P Greenberg; M J Welsh
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

10.  Isolated knee joint infection with Neisseria meningitidis.

Authors:  Shawn Bonsell
Journal:  Orthopedics       Date:  2002-05       Impact factor: 1.390

View more
  131 in total

1.  Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period.

Authors:  Joshua R Stokell; Raad Z Gharaibeh; Timothy J Hamp; Malcolm J Zapata; Anthony A Fodor; Todd R Steck
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

Review 2.  Next-generation sequencing in the analysis of human microbiota: essential considerations for clinical application.

Authors:  Geraint B Rogers; Kenneth D Bruce
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

3.  Characterisation of bacteria in ascites--reporting the potential of culture-independent, molecular analysis.

Authors:  G B Rogers; L E Russell; P G Preston; P Marsh; J E Collins; J Saunders; J Sutton; D Fine; K D Bruce; M Wright
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-18       Impact factor: 3.267

4.  Effects of a composition containing lactoferrin and lactoperoxidase on oral malodor and salivary bacteria: a randomized, double-blind, crossover, placebo-controlled clinical trial.

Authors:  Kouichirou Shin; Ken Yaegaki; Takatoshi Murata; Hisataka Ii; Tomoko Tanaka; Izumi Aoyama; Koji Yamauchi; Tomohiro Toida; Keiji Iwatsuki
Journal:  Clin Oral Investig       Date:  2010-05-29       Impact factor: 3.573

Review 5.  The Microbiome and the Respiratory Tract.

Authors:  Robert P Dickson; John R Erb-Downward; Fernando J Martinez; Gary B Huffnagle
Journal:  Annu Rev Physiol       Date:  2015-11-02       Impact factor: 19.318

6.  Comparison of two fingerprinting techniques, terminal restriction fragment length polymorphism and automated ribosomal intergenic spacer analysis, for determination of bacterial diversity in aquatic environments.

Authors:  R Danovaro; G M Luna; A Dell'anno; B Pietrangeli
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

7.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

Review 8.  The cystic fibrosis airway microbiome.

Authors:  Susan V Lynch; Kenneth D Bruce
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

9.  Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.

Authors:  Geraint B Rogers; Stuart Skelton; David J Serisier; Christopher J van der Gast; Kenneth D Bruce
Journal:  J Clin Microbiol       Date:  2009-11-11       Impact factor: 5.948

10.  Dolosigranulum pigrum: Predicting Severity of Infection.

Authors:  John Sherret; Bhavesh Gajjar; Lamis Ibrahim; Ahmed Mohamed Ahmed; Utsab R Panta
Journal:  Cureus       Date:  2020-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.